{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:46:40Z","timestamp":1765547200536,"version":"3.43.0"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"21","funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J01760"],"award-info":[{"award-number":["2021J01760"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Major Specialty Construction Project of Fujian Province","award":["05029002"],"award-info":[{"award-number":["05029002"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2018Y9053"],"award-info":[{"award-number":["2018Y9053"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Diffuse midline gliomas (DMG) pose a grave threat as a malignant tumor\nprimarily affecting children in the pons region. These tumors exhibit a distinct and heightened resistance to therapeutic interventions, coupled with exceptionally aggressive behavior.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In this study, we accessed DMG data from the Gene Expression Omnibus (GEO)\ndatabase. Subsequently, we performed functional annotation and conducted pathway enrichment\nanalysis as well as gene set enrichment analysis (GSEA). Constructing a protein-protein interaction (PPI) network, we identified pivotal hub genes. To evaluate the impact of these hub genes on\nimmune infiltration, we employed the CIBERSORT algorithm. Furthermore, to bolster our findings, we conducted a single-cell analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Our findings indicate the involvement of CD8A, IL7R, and ICAM1 in immune responses\ntargeting diverse immune cell types, such as T cells, neutrophils, NK cells, dendritic cells, \u03b3\u03b4 T\ncells, and Macrophages M1. Additionally, the presence of immune checkpoints, including IDO1\nand TIGIT, likely contributes to intratumoral immunosuppression, thereby fostering the development of an aggressive phenotype and resistance in pediatric DMG.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In conclusion, the collective findings of our study suggest the potential role of\nCD8A, IL7R, and ICAM1 as innovative biomarkers for diagnosing and prognosticating pediatric\nDMG. Moreover, these molecules hold promise as therapeutic targets in the management of this\ndisease. The implications of our research underscore the importance of exploring these novel avenues for improved patient outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673280120240108045926","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T02:37:20Z","timestamp":1707791840000},"page":"4311-4323","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunosuppressive Microenvironment in H3K27 Mutant Pediatric Diffuse Midline Glioma: Single-Cell and Bioinformatics Insights on CD8A, IL7R, and ICAM1"],"prefix":"10.2174","volume":"32","author":[{"given":"Jianhuang","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Affiliated Hospital of Putian University, Putian, 351100, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiting","family":"You","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fujian\nMedical University Union Hospital, Fuzhou, 350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fujian\nMedical University Union Hospital, Fuzhou, 350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunpeng","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Fujian Medical University,\nFuzhou, 350122, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijing","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Fujian Medical University,\nFuzhou, 350122, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Fujian Medical University,\nFuzhou, 350122, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caihou","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fujian\nMedical University Union Hospital, Fuzhou, 350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian province,\nChina"},{"name":"Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Fuzhou,\nFujian province, China"},{"name":"Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological\nand Breast Malignancies), Fuzhou, Fujian province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"Louis D.N.","year":"2016","unstructured":"Louis D.N.; Perry A.; Reifenberger G.; von Deimling A.; Figarella-Branger D.; Cavenee W.K.; Ohgaki H.; Wiestler O.D.; Kleihues P.; Ellison D.W.; The 2016 world health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol  2016,131(6),803-820","journal-title":"Acta Neuropathol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"Louis D.N.","year":"2021","unstructured":"Louis D.N.; Perry A.; Wesseling P.; Brat D.J.; Cree I.A.; Figarella-Branger D.; Hawkins C.; Ng H.K.; Pfister S.M.; Reifenberger G.; Soffietti R.; von Deimling A.; Ellison D.W.; The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro-oncol  2021,23(8),1231-1251","journal-title":"Neuro-oncol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jpn.JPN_85_20","volume":"16","author":"Nzwalo H.","year":"2021","unstructured":"Nzwalo H.; Espirito Santo V.; Passos J.; Nunes S.; Salgado D.; Remission of pediatric diffuse intrinsic pontine glioma: Case report and review of the literature. J Pediatr Neurosci  2021,16(1),1-4","journal-title":"J Pediatr Neurosci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"Wu G.","year":"2012","unstructured":"Wu G.; Broniscer A.; McEachron T.A.; Lu C.; Paugh B.S.; Becksfort J.; Qu C.; Ding L.; Huether R.; Parker M.; Zhang J.; Gajjar A.; Dyer M.A.; Mullighan C.G.; Gilbertson R.J.; Mardis E.R.; Wilson R.K.; Downing J.R.; Ellison D.W.; Zhang J.; Baker S.J.; Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet  2012,44(3),251-253","journal-title":"Nat Genet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1038\/s41598-023-30395-4","volume":"13","author":"Ajuyah P.","year":"2023","unstructured":"Ajuyah P.; Mayoh C.; Lau L.M.S.; Barahona P.; Wong M.; Chambers H.; Valdes-Mora F.; Senapati A.; Gifford A.J.; D\u2019Arcy C.; Hansford J.R.; Manoharan N.; Nicholls W.; Williams M.M.; Wood P.J.; Cowley M.J.; Tyrrell V.; Haber M.; Ekert P.G.; Ziegler D.S.; Khuong-Quang D.A.; Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes. Sci Rep  2023,13(1),3775","journal-title":"Sci Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-020-03553-1","volume":"150","author":"Cooney T.M.","year":"2020","unstructured":"Cooney T.M.; Lubanszky E.; Prasad R.; Hawkins C.; Mueller S.; Diffuse midline glioma: Review of epigenetics. J Neurooncol  2020,150(1),27-34","journal-title":"J Neurooncol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","volume":"35","author":"Larson J.D.","year":"2019","unstructured":"Larson J.D.; Kasper L.H.; Paugh B.S.; Jin H.; Wu G.; Kwon C.H.; Fan Y.; Shaw T.I.; Silveira A.B.; Qu C.; Xu R.; Zhu X.; Zhang J.; Russell H.R.; Peters J.L.; Finkelstein D.; Xu B.; Lin T.; Tinkle C.L.; Patay Z.; Onar-Thomas A.; Pounds S.B.; McKinnon P.J.; Ellison D.W.; Zhang J.; Baker S.J.; Histone H3.3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression. Cancer Cell  2019,35(1),140-155.e7","journal-title":"Cancer Cell"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-019-0727-1","volume":"7","author":"Qi J.","year":"2019","unstructured":"Qi J.; Esfahani D.R.; Huang T.; Ozark P.; Bartom E.; Hashizume R.; Bonner E.R.; An S.; Horbinski C.M.; James C.D.; Saratsis A.M.; Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease. Acta Neuropathol Commun  2019,7(1),75","journal-title":"Acta Neuropathol Commun"},{"key":"ref=9","first-page":"319","volume":"51","author":"Li J.","year":"2022","unstructured":"Li J.; Ma Y.Y.; Feng J.; Zhao D.; Ding F.; Tian L.; Chen R.; Zhao R.; Diffuse midline gliomas with H3K27 alteration in children: A clinicopathological analysis of forty-one cases. Zhonghua Bing Li Xue Za Zhi  2022,51(4),319-325","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11060-014-1448-8","volume":"119","author":"Robison N.J.","year":"2014","unstructured":"Robison N.J.; Kieran M.W.; Diffuse intrinsic pontine glioma: A reassessment. J Neurooncol  2014,119(1),7-15","journal-title":"J Neurooncol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/ijms21020490","volume":"21","author":"Nikolaev A.","year":"2020","unstructured":"Nikolaev A.; Fiveash J.B.; Yang E.S.; Combined targeting of mutant p53 and jumonji family histone demethylase augments therapeutic efficacy of radiation in H3K27M DIPG. Int J Mol Sci  2020,21(2),490","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/1078-0432.CCR-18-3890","volume":"25","author":"Katagi H.","year":"2019","unstructured":"Katagi H.; Louis N.; Unruh D.; Sasaki T.; He X.; Zhang A.; Ma Q.; Piunti A.; Shimazu Y.; Lamano J.B.; Carcaboso A.M.; Tian X.; Seluanov A.; Gorbunova V.; Laurie K.L.; Kondo A.; Wadhwani N.R.; Lulla R.; Goldman S.; Venneti S.; Becher O.J.; Zou L.; Shilatifard A.; Hashizume R.; Radiosensitization by histone H3 demethylase inhibition in diffuse intrinsic pontine glioma. Clin Cancer Res  2019,25(18),5572-5583","journal-title":"Clin Cancer Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s40495-018-0141-6","volume":"4","author":"Wan Y.C.E.","year":"2018","unstructured":"Wan Y.C.E.; Liu J.; Chan K.M.; Histone H3 mutations in cancer. Curr Pharmacol Rep  2018,4(4),292-300","journal-title":"Curr Pharmacol Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.4293","volume":"23","author":"Mohammad F.","year":"2017","unstructured":"Mohammad F.; Weissmann S.; Leblanc B.; Pandey D.P.; H\u00f8jfeldt J.W.; Comet I.; Zheng C.; Johansen J.V.; Rapin N.; Porse B.T.; Tvardovskiy A.; Jensen O.N.; Olaciregui N.G.; Lavarino C.; Su\u00f1ol M.; de Torres C.; Mora J.; Carcaboso A.M.; Helin K.; EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nat Med  2017,23(4),483-492","journal-title":"Nat Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.aao4750","volume":"360","author":"Filbin M.G.","year":"2018","unstructured":"Filbin M.G.; Tirosh I.; Hovestadt V.; Shaw M.L.; Escalante L.E.; Mathewson N.D.; Neftel C.; Frank N.; Pelton K.; Hebert C.M.; Haberler C.; Yizhak K.; Gojo J.; Egervari K.; Mount C.; van Galen P.; Bonal D.M.; Nguyen Q.D.; Beck A.; Sinai C.; Czech T.; Dorfer C.; Goumnerova L.; Lavarino C.; Carcaboso A.M.; Mora J.; Mylvaganam R.; Luo C.C.; Peyrl A.; Popovi\u0107 M.; Azizi A.; Batchelor T.T.; Frosch M.P.; Martinez-Lage M.; Kieran M.W.; Bandopadhayay P.; Beroukhim R.; Fritsch G.; Getz G.; Rozenblatt-Rosen O.; Wucherpfennig K.W.; Louis D.N.; Monje M.; Slavc I.; Ligon K.L.; Golub T.R.; Regev A.; Bernstein B.E.; Suv\u00e0 M.L.; Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science  2018,360(6386),331-335","journal-title":"Science"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","volume":"18","author":"Yang J.","year":"2019","unstructured":"Yang J.; Nie J.; Ma X.; Wei Y.; Peng Y.; Wei X.; Targeting PI3K in cancer: Mechanisms and advances in clinical trials. Mol Cancer  2019,18(1),26","journal-title":"Mol Cancer"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/brain\/awaa382","volume":"144","author":"Ross J.L.","year":"2021","unstructured":"Ross J.L.; Chen Z.; Herting C.J.; Grabovska Y.; Szulzewsky F.; Puigdelloses M.; Monterroza L.; Switchenko J.; Wadhwani N.R.; Cimino P.J.; Mackay A.; Jones C.; Read R.D.; MacDonald T.J.; Schniederjan M.; Becher O.J.; Hambardzumyan D.; Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma. Brain  2021,144(1),53-69","journal-title":"Brain"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.molimm.2019.10.026","volume":"117","author":"Gao Y.","year":"2020","unstructured":"Gao Y.; Fang P.; Li W.J.; Zhang J.; Wang G.P.; Jiang D.F.; Chen F.P.; LncRNA NEAT1 sponges miR-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma. Mol Immunol  2020,117,20-28","journal-title":"Mol Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","volume":"603","author":"Majzner R.G.","year":"2022","unstructured":"Majzner R.G.; Ramakrishna S.; Yeom K.W.; Patel S.; Chinnasamy H.; Schultz L.M.; Richards R.M.; Jiang L.; Barsan V.; Mancusi R.; Geraghty A.C.; Good Z.; Mochizuki A.Y.; Gillespie S.M.; Toland A.M.S.; Mahdi J.; Reschke A.; Nie E.H.; Chau I.J.; Rotiroti M.C.; Mount C.W.; Baggott C.; Mavroukakis S.; Egeler E.; Moon J.; Erickson C.; Green S.; Kunicki M.; Fujimoto M.; Ehlinger Z.; Reynolds W.; Kurra S.; Warren K.E.; Prabhu S.; Vogel H.; Rasmussen L.; Cornell T.T.; Partap S.; Fisher P.G.; Campen C.J.; Filbin M.G.; Grant G.; Sahaf B.; Davis K.L.; Feldman S.A.; Mackall C.L.; Monje M.; GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature  2022,603(7903),934-941","journal-title":"Nature"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/labinvest.2017.19","volume":"97","author":"Gieryng A.","year":"2017","unstructured":"Gieryng A.; Pszczolkowska D.; Walentynowicz K.A.; Rajan W.D.; Kaminska B.; Immune microenvironment of gliomas. Lab Invest  2017,97(5),498-518","journal-title":"Lab Invest"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"103453","DOI":"10.1016\/j.ebiom.2021.103453","volume":"69","author":"Price G.","year":"2021","unstructured":"Price G.; Bouras A.; Hambardzumyan D.; Hadjipanayis C.G.; Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma. EBioMedicine  2021,69,103453","journal-title":"EBioMedicine"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","volume":"6","author":"Lin G.L.","year":"2018","unstructured":"Lin G.L.; Nagaraja S.; Filbin M.G.; Suv\u00e0 M.L.; Vogel H.; Monje M.; Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma. Acta Neuropathol Commun  2018,6(1),51","journal-title":"Acta Neuropathol Commun"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/neuonc\/noy145","volume":"21","author":"Lieberman N.A.P.","year":"2019","unstructured":"Lieberman N.A.P.; DeGolier K.; Kovar H.M.; Davis A.; Hoglund V.; Stevens J.; Winter C.; Deutsch G.; Furlan S.N.; Vitanza N.A.; Leary S.E.S.; Crane C.A.; Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Neuro-oncol  2019,21(1),83-94","journal-title":"Neuro-oncol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1158\/1078-0432.CCR-15-2834","volume":"22","author":"Ock C.Y.","year":"2016","unstructured":"Ock C.Y.; Keam B.; Kim S.; Lee J.S.; Kim M.; Kim T.M.; Jeon Y.K.; Kim D.W.; Chung D.H.; Heo D.S.; Pan-cancer immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T-cell infiltration. Clin Cancer Res  2016,22(9),2261-2270","journal-title":"Clin Cancer Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.21037\/atm-20-6486","volume":"8","author":"Ma K.","year":"2020","unstructured":"Ma K.; Qiao Y.; Wang H.; Wang S.; Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma. Ann Transl Med  2020,8(22),1478","journal-title":"Ann Transl Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"974416","DOI":"10.3389\/fgene.2022.974416","volume":"13","author":"Niu D.","year":"2022","unstructured":"Niu D.; Chen Y.; Mi H.; Mo Z.; Pang G.; The epiphany derived from T-cell\u2013inflamed profiles: Pan-cancer characterization of CD8A as a biomarker spanning clinical relevance, cancer prognosis, immunosuppressive environment, and treatment responses. Front Genet  2022,13,974416","journal-title":"Front Genet"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1158\/1078-0432.CCR-20-2790","volume":"27","author":"Lei M.","year":"2021","unstructured":"Lei M.; Siemers N.O.; Pandya D.; Chang H.; Sanchez T.; Harbison C.; Szabo P.M.; Janjigian Y.; Ott P.A.; Sharma P.; Bendell J.; Evans T.R.J.; de Braud F.; Chau I.; Boyd Z.; Analyses of PD-L1 and inflammatory gene expression association with efficacy of nivolumab \u00b1 ipilimumab in gastric cancer\/gastroesophageal junction cancer. Clin Cancer Res  2021,27(14),3926-3935","journal-title":"Clin Cancer Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.3390\/cancers14194866","volume":"14","author":"Zheng Z.","year":"2022","unstructured":"Zheng Z.; Guo Y.; Huang X.; Liu J.; Wang R.; Qiu X.; Liu S.; CD8A as a prognostic and immunotherapy predictive biomarker can be evaluated by MRI radiomics features in bladder cancer. Cancers  2022,14(19),4866","journal-title":"Cancers"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00381-020-04665-9","volume":"36","author":"Zhang L.","year":"2020","unstructured":"Zhang L.; Yu H.; Xue Y.; Liu Y.; Decreased natural killer cells in diffuse intrinsic pontine glioma patients. Childs Nerv Syst  2020,36(7),1345-1346","journal-title":"Childs Nerv Syst"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"Boutilier A.J.","year":"2021","unstructured":"Boutilier A.J.; Elsawa S.F.; Macrophage polarization states in the tumor microenvironment. Int J Mol Sci  2021,22(13),6995","journal-title":"Int J Mol Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.07.004","volume":"66","author":"Allavena P.","year":"2008","unstructured":"Allavena P.; Sica A.; Solinas G.; Porta C.; Mantovani A.; The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages. Crit Rev Oncol Hematol  2008,66(1),1-9","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e33998","DOI":"10.1371\/journal.pone.0033998","volume":"7","author":"Pearson C.","year":"2012","unstructured":"Pearson C.; Silva A.; Seddon B.; Exogenous amino acids are essential for interleukin-7 induced CD8 T cell growth. [corrected]. PLoS One  2012,7(4),e33998","journal-title":"PLoS One"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","volume":"20","author":"Barata J.T.","year":"2019","unstructured":"Barata J.T.; Durum S.K.; Seddon B.; Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol  2019,20(12),1584-1593","journal-title":"Nat Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"10412","DOI":"10.3390\/ijms231810412","volume":"23","author":"Wang C.","year":"2022","unstructured":"Wang C.; Kong L.; Kim S.; Lee S.; Oh S.; Jo S.; Jang I.; Kim T.D.; The role of IL-7 and IL-7R in cancer pathophysiology and immunotherapy. Int J Mol Sci  2022,23(18),10412","journal-title":"Int J Mol Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1128\/JVI.78.11.6033-6042.2004","volume":"78","author":"Lum J.J.","year":"2004","unstructured":"Lum J.J.; Schnepple D.J.; Nie Z.; Sanchez-Dardon J.; Mbisa G.L.; Mihowich J.; Hawley N.; Narayan S.; Kim J.E.; Lynch D.H.; Badley A.D.; Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. J Virol  2004,78(11),6033-6042","journal-title":"J Virol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ni.2494","volume":"14","author":"Kimura M.Y.","year":"2013","unstructured":"Kimura M.Y.; Pobezinsky L.A.; Guinter T.I.; Thomas J.; Adams A.; Park J.H.; Tai X.; Singer A.; IL-7 signaling must be intermittent, not continuous, during CD8 T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  2013,14(2),143-151","journal-title":"Nat Immunol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nri2023","volume":"7","author":"Mazzucchelli R.","year":"2007","unstructured":"Mazzucchelli R.; Durum S.K.; Interleukin-7 receptor expression: Intelligent design. Nat Rev Immunol  2007,7(2),144-154","journal-title":"Nat Rev Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"857289","DOI":"10.3389\/fphar.2022.857289","volume":"13","author":"Wang X.","year":"2022","unstructured":"Wang X.; Chang S.; Wang T.; Wu R.; Huang Z.; Sun J.; Liu J.; Yu Y.; Mao Y.; IL7R Is correlated with immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Front Pharmacol  2022,13,857289","journal-title":"Front Pharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e27357","DOI":"10.4161\/onci.27357","volume":"3","author":"Ellsworth S.","year":"2014","unstructured":"Ellsworth S.; Balmanoukian A.; Kos F.; Nirschl C.J.; Nirschl T.R.; Grossman S.A.; Luznik L.; Drake C.G.; Sustained CD4  T cell-driven lymphopenia without a compensatory IL-7\/IL-15 response among high-grade glioma patients treated with radiation and temozolomide. OncoImmunology  2014,3(1),e27357","journal-title":"OncoImmunology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2013.02.017","volume":"258","author":"Fritzell S.","year":"2013","unstructured":"Fritzell S.; Eberst\u00e5l S.; Sand\u00e9n E.; Visse E.; Darabi A.; Siesj\u00f6 P.; IFN\u03b3 in combination with IL-7 enhances immunotherapy in two rat glioma models. J Neuroimmunol  2013,258(1-2),91-95","journal-title":"J Neuroimmunol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00917121","volume":"9","author":"Frohman E.M.","year":"1989","unstructured":"Frohman E.M.; van den Noort S.; Gupta S.; Astrocytes and intracerebral immune responses. J Clin Immunol  1989,9(1),1-9","journal-title":"J Clin Immunol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s004410050602","volume":"284","author":"Scholz D.","year":"1996","unstructured":"Scholz D.; Devaux B.; Hirche A.; P\u00f6tzsch B.; Kropp B.; Schaper W.; Schaper J.; Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture. Cell Tissue Res  1996,284(3),415-423","journal-title":"Cell Tissue Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1038\/onc.2012.546","volume":"32","author":"Kesanakurti D.","year":"2013","unstructured":"Kesanakurti D.; Chetty C.; Rajasekhar Maddirela D.; Gujrati M.; Rao J.S.; Essential role of cooperative NF-\u03baB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma. Oncogene  2013,32(43),5144-5155","journal-title":"Oncogene"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.neo.2019.02.006","volume":"21","author":"Lin J.C.","year":"2019","unstructured":"Lin J.C.; Tsai J.T.; Chao T.Y.; Ma H.I.; Liu W.H.; Musashi-1 enhances glioblastoma migration by promoting ICAM1 translation. Neoplasia  2019,21(5),459-468","journal-title":"Neoplasia"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.4049\/jimmunol.1400135","volume":"192","author":"Ramos T.N.","year":"2014","unstructured":"Ramos T.N.; Bullard D.C.; Barnum S.R.; ICAM-1: Isoforms and phenotypes. J Immunol  2014,192(10),4469-4474","journal-title":"J Immunol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3892\/or.9.3.511","volume":"9","author":"Maeda K.","year":"2002","unstructured":"Maeda K.; Kang S.M.; Sawada T.; Nishiguchi Y.; Yashiro M.; Ogawa Y.; Ohira M.; Ishikawa T.; Hirakawa-YS Chung K.; Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol Rep  2002,9(3),511-514","journal-title":"Oncol Rep"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673280120240108045926","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/226880\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673280120240108045926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T05:23:01Z","timestamp":1754284981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/226880\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673280120240108045926","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}